POFUT1 is a GDP-fucose protein O-fucosyltransferase 1 (O-FucT-1; EC 2.4.1.221), the founding member of the CAZy GT65 family. It catalyzes transfer of L-fucose from GDP-beta-L-fucose to the hydroxyl group of a serine or threonine within the consensus C2-X(4,5)-S/T-C3 of epidermal growth factor (EGF)-like repeats, forming an O-linked fucose. Catalysis is strictly dependent on a properly folded, correctly disulfide-bonded EGF domain rather than on the linear sequence alone. Unlike the Golgi type-II membrane fucosyltransferases (FUT1-9), POFUT1 is a soluble enzyme of the endoplasmic reticulum lumen, retained there by a C-terminal KDEL-like motif, so protein O-fucosylation occurs in the ER during biosynthesis of EGF-repeat-containing secretory and cell-surface proteins. Because it modifies only folded EGF domains, POFUT1 has been proposed to participate in a non-canonical ER quality-control/folding-surveillance step for EGF-repeat proteins. Its principal physiological substrates are the Notch receptors (NOTCH1-4): O-fucose added by POFUT1 primes the EGF repeats for elongation by Fringe beta-1,3-N-acetylglucosaminyltransferases, and the resulting O-glycans modulate binding of Notch to its DLL and JAG ligands, making POFUT1 essential for canonical Notch signal transduction in mammals. Loss of POFUT1 abolishes Notch signaling and causes embryonic lethality in mice; in humans, heterozygous loss-of-function (haploinsufficiency) causes the autosomal-dominant reticulate pigmentation disorder Dowling-Degos disease 2.
Definition: A protein folding-coupled process in which an endoplasmic-reticulum-localized protein O-fucosyltransferase selectively modifies properly folded, correctly disulfide-bonded EGF-like repeats with O-linked fucose, stabilizing the folded domain and promoting forward trafficking of the substrate protein out of the ER.
Justification: POFUT1 modifies only folded EGF repeats (PMID:9023546) and is uniquely localized to the ER lumen (PMID:15653671), which led the authors to propose a non-canonical ER quality-control / folding-surveillance role distinct from the calnexin/calreticulin N-glycan pathway. There is no GO term capturing O-fucosylation-coupled ER folding surveillance of EGF-repeat proteins; existing terms cover either generic O-fucosylation (GO:0036066) or generic ER quality control. A specific term would let POFUT1 (and POFUT2) be annotated to this folding-coupled QC function. Proposed as a child of protein folding / ER protein-containing complex quality control; this is a hypothesis flagged for expert review rather than a settled activity.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005783
endoplasmic reticulum
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (PAN-GO) inference that POFUT1 is active in the endoplasmic reticulum. This is the correct and core compartment: the active human/mammalian enzyme is a soluble ER-luminal protein retained by a C-terminal KDEL-like motif, and O-fucosylation of EGF-repeat substrates such as Notch occurs in the ER. Concordant with the direct experimental IDA (PMID:15653671) and with the deep-research synthesis favouring ER (not Golgi) as the active compartment. Accept as core.
Supporting Evidence:
PMID:15653671
O-FucT-1 is a soluble protein that localizes to the endoplasmic reticulum (ER)
file:human/POFUT1/POFUT1-deep-research-falcon.md
POFUT1 is consistently described as an ER-localized, soluble luminal enzyme
|
|
GO:0008593
regulation of Notch signaling pathway
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Phylogenetic inference that POFUT1 regulates Notch signaling. This is correct and is the best-supported downstream biological role of POFUT1, independently anchored by experimental IMP (PMID:28334865). However it is a consequence of the core ER catalytic function (O-fucosylation of Notch EGF repeats) rather than the core function itself, so keep as a valid non-core process annotation.
|
|
GO:0036066
protein O-linked glycosylation via fucose
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic inference for the O-fucosylation process. This is the exact biological process POFUT1 carries out and is directly supported by multiple experimental IDA annotations (PMID:11524432, PMID:9023546, PMID:15653671). Core. Accept.
|
|
GO:0046922
peptide-O-fucosyltransferase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic inference of the catalytic activity. GO:0046922 (transfer of alpha-L-fucosyl from GDP-beta-L-fucose to a protein Ser/Thr hydroxyl) is the most specific GO molecular-function term for the EC 2.4.1.221 reaction and is the core activity of POFUT1, directly supported by experimental IDA. Accept.
|
|
GO:0005783
endoplasmic reticulum
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Electronic mapping from the UniProt Subcellular Location (Endoplasmic reticulum). Concordant with the experimental IDA (PMID:15653671) and the KDEL-like ER-retention motif. Correct core location. Accept.
|
|
GO:0007219
Notch signaling pathway
|
IEA
GO_REF:0000002 |
MODIFY |
Summary: InterPro-keyword electronic annotation to the Notch signaling pathway itself. POFUT1 is not a transducing/core component of the Notch pathway; it is an ER enzyme that post-translationally O-fucosylates Notch EGF repeats, thereby regulating the pathway. The more accurate and curator-supported framing is "regulation of Notch signaling pathway" (GO:0008593), which is also the term used for the experimental IMP (PMID:28334865). Modify to the regulation term.
Proposed replacements:
regulation of Notch signaling pathway
|
|
GO:0036066
protein O-linked glycosylation via fucose
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro-based electronic annotation to the O-fucosylation process; identical in content to the experimentally supported IDA annotations. Correct core process. Accept.
|
|
GO:0046922
peptide-O-fucosyltransferase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic annotation derived from the EC 2.4.1.221 / InterPro mapping. This is the correct, specific core molecular function and matches the experimental IDA. Accept.
|
|
GO:0036066
protein O-linked glycosylation via fucose
|
IDA
PMID:11524432 Modification of epidermal growth factor-like repeats with O-... |
ACCEPT |
Summary: Direct experimental evidence: cloning and expression of recombinant human O-FucT-1 reproduced the O-fucosyltransferase enzymatic and kinetic properties of the enzyme purified from CHO cells, establishing that POFUT1 carries out O-linked fucosylation of EGF domains. Core process. Accept.
Supporting Evidence:
PMID:11524432
Expression of a soluble form of human O-FucT-1 in insect cells yielded a protein of the predicted molecular weight with O-FucT-1 kinetic and enzymatic properties similar to those of O-FucT-1 purified from CHO cells
|
|
GO:0036066
protein O-linked glycosylation via fucose
|
IDA
PMID:9023546 Identification of a GDP-L-fucose:polypeptide fucosyltransfer... |
ACCEPT |
Summary: Direct experimental evidence: the original GDP-fucose:polypeptide fucosyltransferase assay demonstrated O-glycosidic attachment of fucose to a Ser/Thr in EGF domains, with a requirement for a properly folded (disulfide-bonded) EGF domain. Core process. Accept.
Supporting Evidence:
PMID:9023546
The enzyme catalyzes the reaction that attaches fucose through an O-glycosidic linkage to a conserved serine or threonine residue in EGF domains
|
|
GO:0046922
peptide-O-fucosyltransferase activity
|
IDA
PMID:11524432 Modification of epidermal growth factor-like repeats with O-... |
ACCEPT |
Summary: Direct experimental demonstration of peptide-O-fucosyltransferase activity by recombinant human POFUT1 (the paper to which UniProt assigns EC 2.4.1.221). This is the core, defining molecular function of the gene. Accept.
Supporting Evidence:
PMID:11524432
Expression of a soluble form of human O-FucT-1 in insect cells yielded a protein of the predicted molecular weight with O-FucT-1 kinetic and enzymatic properties similar to those of O-FucT-1 purified from CHO cells
|
|
GO:0046922
peptide-O-fucosyltransferase activity
|
IDA
PMID:9023546 Identification of a GDP-L-fucose:polypeptide fucosyltransfer... |
ACCEPT |
Summary: Direct experimental demonstration: the GDP-fucose:polypeptide fucosyltransferase activity was assayed using recombinant factor VII EGF-1 as acceptor and GDP-fucose as donor, with the diagnostic requirement for a correctly folded/disulfide-bonded EGF domain. This is the core molecular function. Accept.
Supporting Evidence:
PMID:9023546
the enzyme appears to require more than just a consensus primary sequence and likely requires that the EGF domain disulfide bonds be properly formed
|
|
GO:0005783
endoplasmic reticulum
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence-similarity transfer of ER localization (from UniProtKB:Q6EV70). Fully concordant with the direct experimental ER localization in human cells (PMID:15653671) and the family expectation. Correct core location. Accept.
|
|
GO:0008593
regulation of Notch signaling pathway
|
IMP
PMID:28334865 Structure of human POFUT1, its requirement in ligand-indepen... |
KEEP AS NON CORE |
Summary: Strong experimental (mutant-phenotype) evidence: CRISPR knockout of POFUT1 in U2OS cells suppresses both normal ligand-dependent Notch1 signaling and the ligand-independent signaling of leukemogenic Notch1 mutants, and blocks delivery of Notch1 to the cell surface; signaling is rescued by wild-type POFUT1 but not efficiently by the active-site R240A variant. POFUT1 thus regulates Notch signaling. This is the best-supported downstream role but is a consequence of the ER catalytic function; keep as a valid non-core process.
Supporting Evidence:
PMID:28334865
Normal and oncogenic signaling are rescued by wild-type POFUT1 but rescue is impaired by an active-site R240A mutation
|
|
GO:0016020
membrane
|
HDA
PMID:19946888 Defining the membrane proteome of NK cells. |
MARK AS OVER ANNOTATED |
Summary: High-throughput mass-spectrometry catalog of the NK-like (YTS) cell membrane proteome (1843 proteins), in which POFUT1 was detected. POFUT1 is a soluble ER-luminal enzyme; detection in a crude membrane preparation is not informative of its true localization and conflicts with the experimentally established soluble ER-luminal localization (PMID:15653671). Generic, trivial "membrane" location; over-annotation.
|
|
GO:0005783
endoplasmic reticulum
|
IDA
PMID:15653671 O-fucosylation of notch occurs in the endoplasmic reticulum. |
ACCEPT |
Summary: Definitive direct experimental localization: human O-FucT-1 is a soluble protein localizing to the ER and retained there by a C-terminal KDEL-like sequence, and O-fucosylation of proteins occurs in the ER. This establishes the ER as the core compartment of POFUT1 and is the key reference distinguishing it from the Golgi FUT family. Accept.
Supporting Evidence:
PMID:15653671
O-FucT-1 is retained in the ER by a KDEL-like sequence at its C terminus
|
|
GO:0036066
protein O-linked glycosylation via fucose
|
IDA
PMID:15653671 O-fucosylation of notch occurs in the endoplasmic reticulum. |
ACCEPT |
Summary: Direct experimental evidence that enzymatic addition of O-fucose to proteins (Notch) occurs in the ER, catalyzed by O-FucT-1. Supports the core O-fucosylation process annotation and locates it to the ER. Accept.
Supporting Evidence:
PMID:15653671
enzymatic addition of O-fucose to proteins occurs in the ER
|
|
GO:0046922
peptide-O-fucosyltransferase activity
|
IDA
PMID:15653671 O-fucosylation of notch occurs in the endoplasmic reticulum. |
ACCEPT |
Summary: Direct experimental study of the localization and substrate behavior of protein O-fucosyltransferase 1 (O-FucT-1), which adds O-fucose to EGF-like repeats. Supports the core peptide-O-fucosyltransferase activity. Accept.
Supporting Evidence:
PMID:15653671
protein O-fucosyltransferase 1 (O-FucT-1), which is responsible for adding O-fucose to epidermal growth factor-like repeats
|
|
GO:0016020
membrane
|
IDA
PMID:11524432 Modification of epidermal growth factor-like repeats with O-... |
MARK AS OVER ANNOTATED |
Summary: "Membrane" location inferred from a predicted N-terminal type-II transmembrane sequence in the cloned cDNA. However the same and subsequent work show the active enzyme is largely soluble, and PMID:15653671 demonstrated that the mammalian enzyme is a soluble ER-luminal protein. "membrane" (GO:0016020) is a trivial, uninformative term here and is superseded by the ER (lumen) localization. Over-annotation.
|
|
GO:0016020
membrane
|
IDA
PMID:9023546 Identification of a GDP-L-fucose:polypeptide fucosyltransfer... |
MARK AS OVER ANNOTATED |
Summary: "Membrane" location from the original enzyme purification: most activity was soluble, and only ~37% could be recovered from rat-liver membranes by Triton extraction, attributed to a protease-susceptible stem rather than a stable integral-membrane location. Combined with the later demonstration of soluble ER-luminal localization (PMID:15653671), the generic "membrane" term is uninformative and over-annotated.
|
|
GO:0046922
peptide-O-fucosyltransferase activity
|
TAS
PMID:11698403 Composition of Drosophila melanogaster proteome involved in ... |
ACCEPT |
Summary: TAS annotation of the catalytic activity. The cited paper is a Drosophila melanogaster genome-wide survey of enzymes in fucosylated-glycan metabolism (which identified fly O-fucosyltransferase genes), not a characterization of human POFUT1 activity. The molecular-function term itself is correct and core, but the supporting reference is a weak choice for the human gene; far stronger human IDA evidence (PMID:11524432, PMID:9023546, PMID:15653671) supports the same term. Accept the (correct, core) term but flag the weak/miscited provenance in reference_review; the human IDA annotations are the real support.
|
Q: Does human POFUT1 retain the enzyme-independent chaperone activity described for Drosophila Ofut1 (required for Notch surface expression), or is the mammalian requirement for Notch trafficking entirely catalysis-dependent? PMID:28334865 shows the active-site R240A mutant only partially rescues, and states the mammalian chaperone question is unresolved.
Q: Beyond Notch receptors, which physiological human substrates (e.g. AGRN/agrin and its role in acetylcholine-receptor clustering, Notch ligands DLL1/DLL4/JAG1/JAG2, other EGF-repeat ECM/cell-surface proteins) are O-fucosylated by POFUT1 in vivo, and is any of these functionally significant independent of Notch?
Q: What is the mechanistic basis by which heterozygous POFUT1 loss-of-function (haploinsufficiency) produces the skin-restricted Dowling-Degos disease 2 phenotype while complete loss is embryonic-lethal via global Notch failure?
Experiment: Separation-of-function rescue in POFUT1-null cells comparing wild-type enzyme, catalytically dead active-site mutants (e.g. R240A/S356F), and ER-retention-motif deletions, scoring Notch1 surface delivery, EGF-repeat O-fucosylation by mass spectrometry, and Notch reporter signaling, to dissect catalytic versus chaperone/QC contributions in mammalian cells.
Experiment: Site-resolved glycoproteomic mapping of O-fucose (and Fringe-extended) glycans on endogenous NOTCH1-4 and candidate non-Notch EGF-repeat substrates in POFUT1-knockout versus wild-type cells, to define the in vivo substrate repertoire and the stoichiometry/site occupancy of POFUT1-dependent modification.
Experiment: In vitro folding/stability assays (thermal/chemical unfolding, limited proteolysis) on individual EGF repeats with and without O-fucose to test the proposed folding-stabilization/quality-control function, ideally combined with kinetic measurement of POFUT1 acceptor preference for folded versus reduced/unfolded EGF domains.
=== UNIPROT METADATA ===
UniProt ID: Q9H488
Entry Name: OFUT1_HUMAN
Gene Name: POFUT1
Protein Name: GDP-fucose protein O-fucosyltransferase 1
EC Number: 2.4.1.221
Organism: Homo sapiens (Human)
NCBI Taxonomy ID: 9606
Function: Catalyzes the reaction that attaches fucose through an O- glycosidic linkage to a conserved serine or threonine residue found in the consensus sequence C2-X(4,5)-[S/T]-C3 of EGF domains, where C2 and C3 are the second and third conserved cysteines. Specifically uses GDP- fucose as donor substrate and proper disulfide pairing of the substrate EGF domains is required for fucose transfer. Plays a crucial role in NOTCH signaling. Initial fucosylation of NOTCH by POFUT1 generates a substrate for FRINGE/RFNG, an acetylglucosaminyltransferase that can then extend the fucosylation on the NOTCH EGF repeats. This extended fucosylation is required for optimal ligand binding and canonical NOTCH signaling induced by DLL1 or JAGGED1. Fucosylates AGRN and determines its ability to cluster acetylcholine receptors (AChRs).
Subcellular Location: Endoplasmic reticulum
======================
Prepare a comprehensive literature-backed research report for GO annotation review of the target gene.
Focus on:
Structure the report as:
Use citations for all substantive claims.
POFUT1 (Protein O-fucosyltransferase 1, EC 2.4.1.221) is an endoplasmic reticulum (ER)-localized glycosyltransferase that catalyzes the transfer of fucose from GDP-fucose to serine or threonine residues within properly folded epidermal growth factor-like (EGF) repeats of target proteins (hao2025proteinofucosyltransferasesbiological pages 1-3, holdener2019proteinofucosylationstructure pages 1-3, schneider2017biologicalfunctionsof pages 1-2). The enzyme specifically recognizes the consensus sequence C2-XXXX-[S/T]-C3 in folded EGF repeats and requires proper disulfide bonding for substrate modification (holdener2019proteinofucosylationstructure pages 1-3, hao2025proteinofucosyltransferasesbiological pages 6-9). POFUT1 plays an essential role in NOTCH receptor signaling by modulating ligand-receptor interactions and protein trafficking, making NOTCH receptors its most important and best-validated substrates (hao2025proteinofucosyltransferasesbiological pages 6-9, wang2022significantrolesof pages 1-3, pandey2021multifacetedregulationof pages 1-3). Loss of POFUT1 in mice causes embryonic lethality with defects in somitogenesis, hematopoiesis, and developmental patterning primarily through disruption of NOTCH signaling (ajima2017pofut1pointmutationsthat pages 1-2, hao2025proteinofucosyltransferasesbiological pages 21-22). The enzyme functions as part of a non-canonical ER quality control mechanism where O-fucosylation stabilizes folded EGF repeats and promotes proper trafficking (takeuchi2017oglycosylationmodulatesthe pages 1-2, vasudevan2015petersplussyndrome pages 1-3). While POFUT1 has been implicated in various cancer contexts, these represent context-specific pathological roles rather than core biological functions (feng2024theglycogenealterations pages 1-2, li2024proteinofucosyltransferase1 pages 1-2, hao2025proteinofucosyltransferasesbiological pages 21-22).
POFUT1 functions as a GDP-fucose:protein O-fucosyltransferase (EC 2.4.1.221) that catalyzes the transfer of L-fucose from GDP-fucose to the hydroxyl groups of serine or threonine residues in appropriately folded EGF repeats (hao2025proteinofucosyltransferasesbiological pages 1-3, holdener2019proteinofucosylationstructure pages 1-3, schneider2017biologicalfunctionsof pages 1-2). The enzyme is highly specific for its donor substrate GDP-fucose, which is synthesized in the cytosol via de novo or salvage pathways and transported into the ER by mechanisms that remain incompletely characterized (hao2025proteinofucosyltransferasesbiological pages 1-3, hao2025proteinofucosyltransferasesbiological pages 3-5).
POFUT1 exhibits exquisite selectivity for properly folded, disulfide-bonded EGF repeats containing the consensus sequence C2-X-X-X-X-(S/T)-C3, where C2 and C3 represent the second and third conserved cysteines of the EGF repeat (holdener2019proteinofucosylationstructure pages 1-3, hao2025proteinofucosyltransferasesbiological pages 6-9). This stringent requirement for correct three-dimensional structure distinguishes POFUT1 from enzymes that recognize only linear sequence motifs (holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2). In vitro studies demonstrate that POFUT1 can distinguish between folded and unfolded EGF repeats, modifying only properly structured domains (takeuchi2017oglycosylationmodulatesthe pages 1-2, vasudevan2015petersplussyndrome pages 1-3).
Recent comprehensive analyses identify nearly 100 potential human protein substrates containing the POFUT1 consensus motif within EGF repeats, including NOTCH1-4, AGRN (agrin), DLL1, DLL4, JAG1, JAG2, and numerous extracellular matrix and cell-surface proteins (hao2025proteinofucosyltransferasesbiological pages 6-9, hao2025proteinofucosyltransferasesbiological pages 10-11). However, functional validation is strongest for NOTCH family proteins, which contain multiple POFUT1 modification sites and show clear dependence on O-fucosylation for proper function (hao2025proteinofucosyltransferasesbiological pages 6-9, wang2022significantrolesof pages 1-3, pandey2021multifacetedregulationof pages 1-3).
The addition of O-fucose to EGF repeats serves multiple functions. First, O-fucose stabilizes the folded conformation of EGF repeats through intramolecular interactions with neighboring amino acids, as demonstrated by crystal structure analysis showing the glycan filling a surface groove with multiple protein contacts (takeuchi2017oglycosylationmodulatesthe pages 1-2). Second, in vitro unfolding assays reveal that O-fucose addition increases the stability of individual EGF repeats, and this effect is additive with O-glucose modification by POGLUT1 (takeuchi2017oglycosylationmodulatesthe pages 1-2). Third, the O-fucose moiety serves as an acceptor for further glycan extension by Fringe β1,3-N-acetylglucosaminyltransferases (LFNG, MFNG, RFNG) in the Golgi compartment, generating GlcNAcβ1-3Fuc disaccharides that can be further extended to tetrasaccharides (holdener2019proteinofucosylationstructure pages 1-3, hao2025proteinofucosyltransferasesbiological pages 6-9).
POFUT1 does not require proteolytic processing for activation. Instead, enzymatic activity depends on proper protein folding and ER localization (ajima2017pofut1pointmutationsthat pages 1-2). Mouse studies using CRISPR-generated point mutations at conserved catalytic residues (position 245 and 370-372) revealed that disruption of O-fucosyltransferase activity destabilizes the POFUT1 protein itself, leading to loss of detectable protein by E9.5 despite preserved mRNA levels (ajima2017pofut1pointmutationsthat pages 1-2). Both wild-type and catalytically inactive mutant POFUT1 proteins undergo lysosome-dependent degradation, indicating that enzymatic integrity is coupled to protein stability (ajima2017pofut1pointmutationsthat pages 1-2).
| Aspect | POFUT1 evidence summary |
|---|---|
| Enzyme identity | Protein O-fucosyltransferase 1 (POFUT1); EC 2.4.1.221; systematic activity: GDP-fucose:protein O-fucosyltransferase acting on EGF-repeat-containing proteins in the ER (hao2025proteinofucosyltransferasesbiological pages 1-3, holdener2019proteinofucosylationstructure pages 1-3) |
| Core catalytic reaction | Transfers fucose from GDP-fucose to the hydroxyl group of Ser/Thr residues in appropriately folded EGF repeats of target proteins, generating O-linked fucose on the protein substrate (hao2025proteinofucosyltransferasesbiological pages 1-3, holdener2019proteinofucosylationstructure pages 1-3, schneider2017biologicalfunctionsof pages 1-2) |
| Donor substrate / requirement | GDP-fucose is the required sugar donor; GDP-fucose is synthesized in the cytosol and transported into the ER, where POFUT1 uses it for protein O-fucosylation (hao2025proteinofucosyltransferasesbiological pages 1-3, hao2025proteinofucosyltransferasesbiological pages 3-5) |
| Acceptor substrate class | Folded epidermal growth factor-like (EGF) repeats in secreted and membrane proteins; POFUT1 is distinct from POFUT2, which modifies TSR domains instead (holdener2019proteinofucosylationstructure pages 1-3, schneider2017biologicalfunctionsof pages 1-2) |
| Consensus recognition motif | Canonical POFUT1 acceptor sequence in EGF repeats: C2-X-X-X-X-(S/T)-C3; UniProt-style shorthand in recent review: C2XXXX[S/T]C3 (holdener2019proteinofucosylationstructure pages 1-3, hao2025proteinofucosyltransferasesbiological pages 6-9) |
| Substrate specificity rules | POFUT1 is highly selective for properly folded, disulfide-bonded EGF repeats; enzyme recognition depends on the 3D structure of the EGF repeat, not just the linear motif (holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2, ajima2017pofut1pointmutationsthat pages 1-2) |
| Functional biochemical consequence | Addition of O-fucose stabilizes EGF repeats through intramolecular interactions; together with O-glucose, it improves EGF-repeat stability and supports Notch trafficking and surface expression (takeuchi2017oglycosylationmodulatesthe pages 1-2) |
| Subcellular site of catalysis | Endoplasmic reticulum (ER) lumen; POFUT1 is an ER-localized protein O-fucosyltransferase acting during biosynthesis/quality control of EGF-repeat proteins (hao2025proteinofucosyltransferasesbiological pages 1-3, holdener2019proteinofucosylationstructure pages 1-3, ajima2017pofut1pointmutationsthat pages 1-2) |
| Activation / maturation mechanism | No evidence that POFUT1 requires proteolytic activation. Rather, activity depends on ER localization and intact protein stability; catalytic-site point mutations in mouse Pofut1 destabilize the protein and abolish Notch signaling, with mutant protein becoming undetectable and subject to lysosomal degradation (ajima2017pofut1pointmutationsthat pages 1-2) |
| Major best-supported substrates: NOTCH receptors | NOTCH1-4 are the strongest and best-supported biological substrates; Notch receptors contain many POFUT1 sites and are extensively O-fucosylated on their extracellular EGF repeats (holdener2019proteinofucosylationstructure pages 1-3, hao2025proteinofucosyltransferasesbiological pages 6-9, wang2022significantrolesof pages 1-3, pandey2021multifacetedregulationof pages 1-3) |
| Site-specific Notch details | On NOTCH1, O-fucose on EGF8 and EGF12 directly contributes to ligand interactions with DLL1 and JAG1; different EGF-repeat glycans can have distinct effects on signaling strength (hao2025proteinofucosyltransferasesbiological pages 6-9) |
| Major additional substrates with direct functional support | AGRN (agrin) is a supported non-Notch substrate; O-fucosylation of agrin is linked to its ability to induce acetylcholine receptor clustering at the neuromuscular junction, and AGRN is listed among putative/validated human POFUT1 substrates with disease relevance (hao2025proteinofucosyltransferasesbiological pages 6-9) |
| Ligand substrates / likely POFUT1-modified EGF proteins | Canonical Notch ligands DLL1, DLL4, JAG1, and JAG2 contain EGF repeats and are discussed as EGF-repeat proteins processed through ER/Golgi glycosylation relevant to Notch signaling; JAG1 and JAG2 are included among human proteins with multiple POFUT1 consensus sites in the recent substrate catalog (hao2025proteinofucosyltransferasesbiological pages 6-9, wang2022significantrolesof pages 1-3, hao2025proteinofucosyltransferasesbiological pages 10-11) |
| Broader substrate repertoire | Recent compilation lists nearly 100 potential human substrates with the motif in EGF repeats, including JAG1, JAG2, CD93, CELSR1-3, FBN1/2/3, HSPG2, LRP1, ADGRE family proteins, and many extracellular matrix/cell-surface proteins; however, functional support is strongest for Notch family proteins and selected additional targets such as AGRN (holdener2019proteinofucosylationstructure pages 1-3, hao2025proteinofucosyltransferasesbiological pages 6-9, hao2025proteinofucosyltransferasesbiological pages 10-11) |
| Downstream glycan extension by Fringe | In the Golgi, FRINGE enzymes add β1,3-linked GlcNAc to O-fucose, producing GlcNAcβ1-3Fuc; this can be further elongated to a tetrasaccharide by B4GALT1 and ST6GAL1 (holdener2019proteinofucosylationstructure pages 1-3, hao2025proteinofucosyltransferasesbiological pages 6-9) |
| Fringe family members | Mammalian Fringe enzymes include LFNG (Lunatic Fringe), MFNG (Manic Fringe), and RFNG (Radical Fringe) (holdener2019proteinofucosylationstructure pages 1-3) |
| Functional effect of Fringe extension on Notch | Fringe extension can enhance or inhibit ligand-specific Notch interactions depending on the modified EGF repeat: e.g., Fringe modification on NOTCH1 EGF8/EGF12 enhances binding to DLL1/JAG1, whereas modification on EGF6/EGF36 can inhibit JAG1-dependent activation (hao2025proteinofucosyltransferasesbiological pages 6-9) |
| Bottom-line core molecular function for GO review | The most defensible core molecular-function annotation is GDP-fucose:protein O-fucosyltransferase activity, acting on properly folded EGF-repeat-containing proteins in the ER, with Notch receptor O-fucosylation as the central, best-supported substrate/function axis (hao2025proteinofucosyltransferasesbiological pages 1-3, holdener2019proteinofucosylationstructure pages 1-3, hao2025proteinofucosyltransferasesbiological pages 6-9, ajima2017pofut1pointmutationsthat pages 1-2) |
Table: This table summarizes the core biochemical activity, substrate rules, and principal substrates of human POFUT1, emphasizing evidence most relevant for GO molecular-function review. It distinguishes the well-supported core function on folded EGF repeats—especially Notch receptors—from the broader but less uniformly validated substrate repertoire.
The most extensively validated biological function of POFUT1 is regulation of canonical NOTCH signaling (hao2025proteinofucosyltransferasesbiological pages 6-9, wang2022significantrolesof pages 1-3, pandey2021multifacetedregulationof pages 1-3). NOTCH receptors (NOTCH1-4 in mammals) are heavily O-fucosylated on their extracellular EGF repeats, with some fucose residues playing direct roles in ligand recognition (hao2025proteinofucosyltransferasesbiological pages 6-9). Specifically, O-fucose on NOTCH1 EGF8 and EGF12 directly contributes to interactions with Delta-like ligands (DLL1, DLL4) and Jagged ligands (JAG1, JAG2), and Fringe-mediated extension of these O-fucose residues further enhances ligand binding (hao2025proteinofucosyltransferasesbiological pages 6-9). Different O-fucose sites exert distinct regulatory effects: while Fringe modifications on EGF8 and EGF12 enhance DLL1/JAG1 binding, modifications on EGF6 and EGF36 can inhibit JAG1-dependent activation (hao2025proteinofucosyltransferasesbiological pages 6-9).
Loss of POFUT1 abolishes NOTCH signaling by preventing proper ligand-receptor interactions and disrupting receptor trafficking (ajima2017pofut1pointmutationsthat pages 1-2). Mouse embryonic stem cells lacking Pofut1 express NOTCH receptors on the cell surface but these receptors are non-functional due to inability to bind Delta ligands (pandey2021multifacetedregulationof pages 1-3). Cell-surface expression of endogenous NOTCH1 in mammalian cells depends on the presence of both POFUT1 and POGLUT1 in an additive manner, supporting a cooperative role for ER-localized glycosyltransferases in NOTCH maturation (takeuchi2017oglycosylationmodulatesthe pages 1-2).
Somitogenesis and Embryonic Patterning: POFUT1 is indispensable for proper somite formation during vertebrate embryogenesis (ajima2017pofut1pointmutationsthat pages 1-2). The segmental pattern of the vertebrate body requires cyclic and synchronized activation of NOTCH signaling in the presomitic mesoderm (PSM). Mouse embryos with catalytic-site point mutations in Pofut1 display severely perturbed somite formation and NOTCH1 subcellular localization defects identical to complete Pofut1 null mutants, demonstrating that the O-fucosyltransferase activity is essential for this developmental process (ajima2017pofut1pointmutationsthat pages 1-2).
Hematopoiesis and Lymphoid/Myeloid Development: POFUT1-mediated O-fucosylation is critical for hematopoietic lineage decisions (hao2025proteinofucosyltransferasesbiological pages 21-22). Conditional deletion of Pofut1 in mouse hematopoietic stem cells (HSCs) leads to reduced T-cell development in the thymus, decreased marginal zone B-cell production in the spleen, and increased myeloid cell populations in bone marrow (hao2025proteinofucosyltransferasesbiological pages 21-22). These phenotypes result from loss of NOTCH-DLL4 signaling, as deletion of DLL4 in bone marrow osteocalcin-expressing cells produces similar defects (hao2025proteinofucosyltransferasesbiological pages 21-22). Restoration of NOTCH1 signaling rescues the lymphoid and myeloid abnormalities, confirming that POFUT1 acts primarily through NOTCH pathway regulation in hematopoiesis (hao2025proteinofucosyltransferasesbiological pages 21-22).
Other Developmental Contexts: POFUT1 contributes to skeletal muscle homeostasis, with muscle-specific deletion in mice inducing aging-related phenotypes and altering expression of cell-cycle, NOTCH, Wnt pathway, and myosin genes (hao2025proteinofucosyltransferasesbiological pages 1-3). POFUT1 also promotes uterine and placental angiogenesis through O-fucosylation of substrates including urokinase plasminogen activator (uPA), activating RhoA signaling pathways (hao2025proteinofucosyltransferasesbiological pages 1-3).
POFUT1 plays a validated role at the neuromuscular junction through O-fucosylation of agrin (AGRN), an extracellular matrix protein essential for acetylcholine receptor (AChR) clustering (hao2025proteinofucosyltransferasesbiological pages 6-9). The UniProt annotation states that fucosylation of AGRN by POFUT1 determines its ability to cluster AChRs at the neuromuscular synapse. While this represents an important non-NOTCH substrate, the evidence for broader neuronal signaling roles remains limited to indirect effects through NOTCH-dependent neuronal differentiation and developmental processes.
Disruption of fucose metabolism (via fucose salvage pathway defects) in zebrafish causes neurodevelopmental abnormalities including brain atrophy, locomotor deficits, seizure susceptibility, and behavioral changes, with reduced expression of pofut2 (a related enzyme) and elevated apoptotic activity in the midbrain-hindbrain boundary (hao2025proteinofucosyltransferasesbiological pages 1-3). These findings suggest that protein O-fucosylation broadly supports neurodevelopment, though direct POFUT1-specific neuronal roles require further investigation.
Current evidence does not support a direct pro-apoptotic or anti-apoptotic role for POFUT1 in normal physiology. Cancer studies report that POFUT1 knockdown can induce apoptosis in some tumor cell lines, but this is generally interpreted as a secondary consequence of disrupted oncogenic NOTCH signaling rather than a direct apoptotic function of POFUT1 (hao2025proteinofucosyltransferasesbiological pages 21-22). In developmental contexts, apoptosis phenotypes appear mediated indirectly through NOTCH pathway dysregulation rather than cell-death-specific POFUT1 functions.
Cancer Progression: POFUT1 is frequently overexpressed in multiple human cancers including colorectal cancer, hepatocellular carcinoma, esophageal squamous cell carcinoma, and glioblastoma (feng2024theglycogenealterations pages 1-2, hao2025proteinofucosyltransferasesbiological pages 21-22). Chromosomal amplification of the POFUT1 locus (20q11.21) occurs in colorectal cancer, and elevated POFUT1 expression correlates with tumor progression, metastasis, and poor prognosis (hao2025proteinofucosyltransferasesbiological pages 21-22). In esophageal squamous cell carcinoma, POFUT1 overexpression increases overall fucosylation levels, activates NOTCH signaling, and promotes cell proliferation and migration (feng2024theglycogenealterations pages 1-2). However, a recent study in hepatocellular carcinoma reported that POFUT1 promotes immune evasion by stabilizing PD-L1 protein through a mechanism independent of its catalytic O-fucosyltransferase activity, suggesting potential non-enzymatic functions in specific pathological contexts (li2024proteinofucosyltransferase1 pages 1-2).
These cancer-associated roles represent context-specific pathological functions that should not be conflated with core biological processes in normal development and homeostasis.
| Process category | Biological process role | Evidence summary | NOTCH dependence | Organismal / disease evidence | Evidence strength | Core vs context-specific assessment |
|---|---|---|---|---|---|---|
| Core established | Canonical NOTCH signaling pathway | POFUT1 is the ER-localized O-fucosyltransferase for folded EGF repeats on NOTCH receptors; O-fucose on NOTCH1 EGF8 and EGF12 directly contributes to DLL1/JAG1 ligand interactions, and Fringe extension further modulates signaling strength. Loss of POFUT1 impairs ligand binding and downstream Notch activation (holdener2019proteinofucosylationstructure pages 1-3, hao2025proteinofucosyltransferasesbiological pages 6-9, wang2022significantrolesof pages 1-3, pandey2021multifacetedregulationof pages 1-3, ajima2017pofut1pointmutationsthat pages 1-2) | Directly NOTCH-dependent | Mouse Pofut1 loss causes severe developmental defects; human POFUT1 variants alter NOTCH1 glycosylation and are linked to developmental phenotypes and skin disease; NOTCH pathway reduction seen in affected keratinocytes with POFUT1 loss-of-function (ajima2017pofut1pointmutationsthat pages 1-2, hao2025proteinofucosyltransferasesbiological pages 6-9) | Very strong | Core: this is the central, best-supported biological role of POFUT1 |
| Core established | Somitogenesis / segmentation clock | During mouse somitogenesis, Pofut1 is indispensable for periodic NOTCH1 signaling in presomitic mesoderm. Catalytic-disrupting point mutants phenocopy null mutants, with abolished Notch1 signaling and defective somite formation (ajima2017pofut1pointmutationsthat pages 1-2) | Directly NOTCH-dependent | Mouse CRISPR point mutants and null phenotypes in embryo; loss of Pofut1 protein and defective Notch1 localization/signaling in presomitic mesoderm (ajima2017pofut1pointmutationsthat pages 1-2) | Very strong | Core developmental consequence of POFUT1-mediated Notch regulation |
| Core established | Hematopoiesis / lymphopoiesis / myelopoiesis | O-fucose on NOTCH regulates hematopoietic lineage decisions. Conditional Pofut1 deletion in hematopoietic stem cells reduces T-cell development and marginal zone B cells while increasing myeloid cells; restoration of Notch1 signaling rescues phenotypes (hao2025proteinofucosyltransferasesbiological pages 19-21, hao2025proteinofucosyltransferasesbiological pages 21-22) | Directly NOTCH-dependent | Mouse HSC conditional knockout; impaired DLL/Notch binding and altered blood lineage homeostasis (hao2025proteinofucosyltransferasesbiological pages 19-21, hao2025proteinofucosyltransferasesbiological pages 21-22) | Very strong | Core tissue-specific manifestation of POFUT1–NOTCH biology |
| Core established | Embryonic development | POFUT1 is essential for normal mammalian development, with developmental lethality and widespread defects when absent; this is attributed primarily to disrupted O-fucosylation of NOTCH and related EGF-repeat proteins (schneider2017biologicalfunctionsof pages 1-2, ajima2017pofut1pointmutationsthat pages 1-2) | Largely NOTCH-dependent | Mouse knockout lethality and embryonic patterning defects; multiple human developmental disorders linked to POFUT1 substrates and pathway disruption (schneider2017biologicalfunctionsof pages 1-2, hao2025proteinofucosyltransferasesbiological pages 6-9, ajima2017pofut1pointmutationsthat pages 1-2) | Strong | Core broad organismal role, but mechanistically dominated by Notch pathway effects |
| Developmental, strong support | Skeletal muscle homeostasis / muscle aging-related phenotypes | Deletion of Pofut1 in mouse skeletal myofibers induces muscle aging-related changes and alters expression of cell-cycle, Notch receptor, Wnt-pathway, myosin, and connective tissue genes, indicating an important role in muscle maintenance and signaling crosstalk (hao2025proteinofucosyltransferasesbiological pages 1-3) | Mixed; likely partly NOTCH-dependent, with possible additional pathways | Muscle-specific mouse knockout phenotypes reported in myofibers (hao2025proteinofucosyltransferasesbiological pages 1-3) | Strong | Context-specific developmental/physiological role; supported, but less foundational than global Notch regulation |
| Developmental, strong support | Neuromuscular junction development via AGRN / AChR clustering | AGRN is a supported POFUT1 substrate; O-fucosylation of agrin determines its ability to cluster acetylcholine receptors, linking POFUT1 to neuromuscular junction organization (hao2025proteinofucosyltransferasesbiological pages 6-9) | Best interpreted as NOTCH-independent substrate-specific role | Human disease association through AGRN-related congenital myasthenic syndrome noted in substrate tables; mechanistic role tied to agrin function at NMJ (hao2025proteinofucosyltransferasesbiological pages 6-9) | Strong | Important but narrower non-Notch role; should be annotated cautiously as substrate-specific rather than broad neuronal signaling |
| Developmental, strong support | Uterine / placental angiogenesis and vascular remodeling | poFUT1 promotes uterine angiogenesis and vascular remodeling by enhancing O-fucosylation of uPA and activating RhoA signaling, supporting a vascular role outside canonical Notch contexts (ajima2017pofut1pointmutationsthat pages 1-2) | Reported as NOTCH-independent in this study | Human endometrium correlations and mouse model evidence in reproductive tissues (ajima2017pofut1pointmutationsthat pages 1-2) | Moderate to strong | Context-specific; evidence exists, but role is specialized and should not be overgeneralized to all angiogenesis |
| Developmental, moderate support | Notch-regulated intestinal and immune development | Reviews summarize that O-fucose glycans on NOTCH1/2 are required for optimal ligand-dependent signaling in intestine and immune compartments, affecting stem-cell fate and lineage decisions (pandey2021multifacetedregulationof pages 1-3, hao2025proteinofucosyltransferasesbiological pages 21-22) | Directly NOTCH-dependent | Mouse intestinal and immune studies summarized in reviews (pandey2021multifacetedregulationof pages 1-3, hao2025proteinofucosyltransferasesbiological pages 21-22) | Strong review-level support | Derivative/core-adjacent: valid as downstream Notch biology, but less direct than hematopoiesis/somitogenesis evidence |
| Pathological | Cancer progression via enhanced NOTCH signaling | POFUT1 is overexpressed in multiple cancers, including esophageal squamous cell carcinoma and glioblastoma; overexpression increases fucosylation, activates Notch signaling, and promotes proliferation, migration, EMT, metastasis, or tumor growth (feng2024theglycogenealterations pages 1-2, hao2025proteinofucosyltransferasesbiological pages 21-22) | Often NOTCH-dependent, though not universally | Human tumor expression/prognosis associations and cell/xenograft studies in ESCC, CRC, GBM, and other tumors summarized in recent papers/reviews (feng2024theglycogenealterations pages 1-2, hao2025proteinofucosyltransferasesbiological pages 21-22) | Strong for association; variable for mechanism by cancer type | Context-specific pathological role; should not be mistaken for a normal core biological process |
| Pathological | Immune evasion in liver cancer | In HCC, POFUT1 promotes immune evasion by stabilizing PD-L1 and reducing T-cell infiltration. This effect was reported to occur independently of its O-fucosyltransferase catalytic activity, and POFUT1 inhibition synergized with anti-PD-1 therapy in mouse models (li2024proteinofucosyltransferase1 pages 1-2) | Reported as NOTCH-independent and catalysis-independent | De novo MYC/Trp53-/- and xenograft mouse liver tumor models; high POFUT1 expression associated with poorer response to ICB clinically (li2024proteinofucosyltransferase1 pages 1-2) | Strong within HCC context | Highly context-specific / annotation-risk: important cancer biology, but not a safe basis for normal-process GO annotation to POFUT1 catalytic function |
| Pathological | Apoptosis-related phenotypes in cancer cells | Reviews note that POFUT1 knockdown can induce apoptosis in some cancer cells, but this is generally interpreted as a secondary consequence of altered oncogenic signaling rather than a direct apoptotic function of POFUT1 (hao2025proteinofucosyltransferasesbiological pages 21-22) | Usually indirect, often through NOTCH dysregulation | Cancer cell line and tumor studies; not established as a conserved direct role in healthy tissues (hao2025proteinofucosyltransferasesbiological pages 21-22) | Moderate / indirect | Over-extension risk: avoid annotating direct apoptosis roles without substrate- and context-specific evidence |
| Exclusion / caution | Pyroptosis, inflammatory signaling, synaptic remodeling, nuclear/cytosolic signaling complex localization | No strong evidence in the gathered literature supports direct POFUT1 function in pyroptosis, canonical inflammatory signaling complexes, synaptic remodeling beyond AGRN-mediated NMJ effects, or localization/function in cytosol, nucleus, or plasma-membrane signaling complexes. POFUT1 is best supported as an ER luminal enzyme acting during secretory-pathway maturation (holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2, ajima2017pofut1pointmutationsthat pages 1-2) | Not applicable | Available evidence instead supports ER localization and secretory-pathway function (holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2, ajima2017pofut1pointmutationsthat pages 1-2) | Strong negative/cautionary inference | Do not treat as core; these would be over-extended annotations based on current evidence |
Table: This table summarizes the strongest supported biological processes linked to human POFUT1, distinguishing core conserved functions from context-specific developmental and pathological roles. It is useful for GO review because it highlights where annotation is well supported versus where over-extension risk is high.
POFUT1 is consistently described as an ER-localized, soluble luminal enzyme that modifies folded EGF repeats during biosynthesis in the secretory pathway (hao2025proteinofucosyltransferasesbiological pages 1-3, holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2, ajima2017pofut1pointmutationsthat pages 1-2). This localization distinguishes POFUT1 from Golgi-localized fucosyltransferases (FUT1-9), which are type II transmembrane proteins that modify glycan structures rather than directly linking fucose to protein (hao2025proteinofucosyltransferasesbiological pages 3-5, holdener2019proteinofucosylationstructure pages 1-3).
POFUT1 participates in a non-canonical ER quality control mechanism distinct from the classical calnexin/calreticulin N-glycan-dependent folding pathway (takeuchi2017oglycosylationmodulatesthe pages 1-2, vasudevan2015petersplussyndrome pages 1-3). While conventional ER quality control recognizes and tags unfolded proteins for retention or degradation, POFUT1 recognizes and glycosylates properly folded EGF repeats, thereby stabilizing the folded structure and accelerating the net folding rate (takeuchi2017oglycosylationmodulatesthe pages 1-2, vasudevan2015petersplussyndrome pages 1-3). This folding-coupled modification occurs cotranslationally or during early secretory pathway maturation as nascent EGF-repeat-containing proteins fold in the ER lumen (takeuchi2017oglycosylationmodulatesthe pages 1-2, vasudevan2015petersplussyndrome pages 1-3).
The functional importance of this quality control role is demonstrated by studies showing that combined loss of POGLUT1 and POFUT1 additively impairs cell-surface expression of endogenous NOTCH1, whereas O-glycans stabilize individual EGF repeats in an additive manner in vitro (takeuchi2017oglycosylationmodulatesthe pages 1-2). Mass spectrometry analysis reveals that TSRs from mature secreted proteins are stoichiometrically modified with O-fucose-containing glycans, whereas TSRs still folding in the ER are only partially modified, supporting the model that O-glycosylation marks folded domains and promotes ER exit (vasudevan2015petersplussyndrome pages 1-3).
The current literature provides no support for active POFUT1 localization or function in cytoplasm, cytosol, nucleus, Golgi apparatus, plasma membrane, or extracellular signaling complexes (holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2, ajima2017pofut1pointmutationsthat pages 1-2). While POFUT1 affects cell-surface receptor signaling by modifying NOTCH and other proteins during biosynthesis, the enzyme itself does not localize to receptor signaling complexes at the plasma membrane. Similarly, nuclear and cytoplasmic O-fucosylation described in plants (SPINDLY) and protozoans involves unrelated enzyme systems distinct from mammalian POFUT1 (holdener2019proteinofucosylationstructure pages 1-3).
There is no evidence for stable multiprotein complexes containing active POFUT1. The enzyme functions through transient substrate-enzyme interactions with folded EGF-repeat-containing proteins in the ER lumen (holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2).
| Aspect | Evidence summary | GO/annotation implication | Risk assessment |
|---|---|---|---|
| Confirmed subcellular localization | POFUT1 is consistently described as an endoplasmic reticulum (ER)-localized protein O-fucosyltransferase that modifies folded EGF repeats during biosynthesis in the secretory pathway (hao2025proteinofucosyltransferasesbiological pages 1-3, holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2, ajima2017pofut1pointmutationsthat pages 1-2) | Strong support for endoplasmic reticulum lumen / ER-resident glycosyltransferase localization terms | Low risk for ER annotation |
| Soluble ER luminal enzyme vs membrane-associated | Reviews and mechanistic studies describe POFUT1 as an ER-localized enzyme in the ER lumen that recognizes folded EGF repeats; unlike Golgi FUT1-9, which are type II membrane proteins, POFUT1 is grouped with ER-localized POFUTs rather than Golgi membrane FUTs (hao2025proteinofucosyltransferasesbiological pages 3-5, holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2, ajima2017pofut1pointmutationsthat pages 1-2) | Best annotation is ER luminal enzyme, not plasma membrane or Golgi transmembrane fucosyltransferase | Moderate risk of confusion with Golgi FUT family if only “fucosyltransferase” is considered |
| Role in ER quality control | POFUT1 modifies only properly folded, disulfide-bonded EGF repeats, indicating structure-dependent substrate surveillance in the ER. O-fucose stabilizes EGF repeats and, together with O-glucose, supports folding, trafficking, and cell-surface expression of Notch (holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2) | Supports annotation to protein O-fucosylation, protein folding quality control, and ER-associated maturation/trafficking of EGF-repeat proteins | Low risk if phrased as ER quality-control/folding support rather than generic chaperone activity |
| Protein folding/trafficking consequence | In HEK293T cells, cell-surface expression of endogenous Notch1 depends additively on POGLUT1 and POFUT1; O-fucose increases EGF-repeat stability through intramolecular interactions, providing a mechanistic basis for improved trafficking (takeuchi2017oglycosylationmodulatesthe pages 1-2) | Supports biological-process annotations related to Notch receptor maturation/trafficking | Moderate risk of overextending to all cargo trafficking rather than EGF-repeat-containing substrates |
| Evidence against cytoplasm/cytosol localization | The gathered evidence places POFUT1 in the ER secretory pathway; no direct evidence in these sources supports active localization or catalytic function in the cytoplasm/cytosol (holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2, ajima2017pofut1pointmutationsthat pages 1-2) | Avoid cytoplasm/cytosol GO cellular-component annotations | High risk if inferred from non-mammalian nucleocytoplasmic O-fucosyltransferases such as SPINDLY, which are unrelated in localization/function (holdener2019proteinofucosylationstructure pages 1-3) |
| Evidence against nuclear localization | No evidence in the cited mammalian POFUT1 literature supports nuclear localization. Nuclear/cytoplasmic O-fucosylation discussed in plants/protozoa involves different enzymes, not mammalian POFUT1 (holdener2019proteinofucosylationstructure pages 1-3) | Do not annotate nucleus/nucleoplasm for human POFUT1 | High risk of false transfer from SPINDLY-like systems |
| Evidence against Golgi localization | POFUT1 acts in the ER, while Fringe-mediated extension of the O-fucose glycan occurs later in the Golgi; thus Golgi localization applies to downstream glycan extension enzymes, not to POFUT1 itself (holdener2019proteinofucosylationstructure pages 1-3, hao2025proteinofucosyltransferasesbiological pages 6-9, wang2022significantrolesof pages 1-3) | Avoid assigning POFUT1 to Golgi apparatus based on pathway adjacency | Moderate to high risk because fucosylation pathways often involve Golgi enzymes, but POFUT1 is not one of them |
| Evidence against plasma membrane/signaling complex localization | POFUT1 affects ligand binding and signaling by modifying Notch pathway proteins during biosynthesis, but the evidence does not place active POFUT1 at the plasma membrane or in cell-surface signaling complexes (hao2025proteinofucosyltransferasesbiological pages 6-9, wang2022significantrolesof pages 1-3, ajima2017pofut1pointmutationsthat pages 1-2) | Annotate upstream biosynthetic regulation of signaling, not residence in receptor signaling complexes | High risk if signaling phenotype is mistaken for physical localization at the membrane |
| Protein stability of POFUT1 itself | Mouse catalytic-disrupting Pofut1 point mutants caused loss of detectable Pofut1 protein despite preserved RNA, showing that enzymatic-site integrity affects protein stability. Both wild-type and mutant Pofut1 proteins were reported to undergo lysosome-dependent degradation (ajima2017pofut1pointmutationsthat pages 1-2) | Supports cautious annotation to protein stability/homeostasis of POFUT1 itself, but mainly from mutant studies | Moderate risk: this is informative mechanistically, but not equivalent to a normal core biological role |
| Cotranslational vs post-translational timing | ER glycosylation of TSRs is shown cotranslationally for POFUT2 systems, and for POFUT1 the literature supports modification during ER folding/biogenesis of EGF repeats, i.e., early in secretory-pathway maturation rather than after cell-surface delivery. Reviews describe ER O-fucosylation as occurring as proteins fold and traffic through the secretory pathway (holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2, vasudevan2015petersplussyndrome pages 1-3) | Best interpreted as early secretory-pathway, folding-coupled modification; avoid late extracellular or plasma-membrane modification models | Moderate risk if timing is overstated as definitively cotranslational for every substrate |
| Active complexes | The current evidence supports substrate-enzyme interactions with folded EGF-repeat proteins, but not a stable named multiprotein complex for active POFUT1 function (holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2) | Prefer annotations to ER lumen and protein O-fucosyltransferase activity over specific complex membership | Low risk if no complex term is assigned |
| Overall localization annotation guidance | The most defensible localization model is: soluble ER luminal glycosyltransferase participating in folding-sensitive maturation of secretory-pathway EGF-repeat proteins; there is insufficient support for cytosolic, nuclear, Golgi, plasma membrane, or signaling-complex localization (hao2025proteinofucosyltransferasesbiological pages 1-3, holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2, ajima2017pofut1pointmutationsthat pages 1-2) | Prioritize ER lumen / endoplasmic reticulum; avoid broader localization terms unsupported by direct evidence | High value for GO review because many alternative localizations would likely be over-annotations |
Table: This table summarizes the strongest evidence for POFUT1 as an ER luminal, folding-sensitive glycosyltransferase and highlights which alternative localization annotations are weak or unsupported. It is useful for GO review because it separates true subcellular localization evidence from pathway-level signaling effects.
Molecular Function: The most defensible molecular function annotation is GDP-fucose:protein O-fucosyltransferase activity (EC 2.4.1.221) acting on properly folded EGF-repeat-containing proteins in the ER (hao2025proteinofucosyltransferasesbiological pages 1-3, holdener2019proteinofucosylationstructure pages 1-3, hao2025proteinofucosyltransferasesbiological pages 6-9).
Biological Process: NOTCH signaling pathway regulation represents the core, best-supported biological process, with robust experimental evidence from mouse genetics, cell biology, and structural studies (hao2025proteinofucosyltransferasesbiological pages 6-9, wang2022significantrolesof pages 1-3, pandey2021multifacetedregulationof pages 1-3, ajima2017pofut1pointmutationsthat pages 1-2). Somitogenesis, hematopoiesis, and embryonic development represent validated developmental contexts where POFUT1 function is experimentally demonstrated (ajima2017pofut1pointmutationsthat pages 1-2, hao2025proteinofucosyltransferasesbiological pages 21-22).
Cellular Component: Endoplasmic reticulum (ER lumen) is strongly supported with no contradictory evidence (hao2025proteinofucosyltransferasesbiological pages 1-3, holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2, ajima2017pofut1pointmutationsthat pages 1-2).
Developmental Processes: While POFUT1 clearly functions in somitogenesis and hematopoiesis through NOTCH signaling, these represent tissue-specific manifestations of core NOTCH biology rather than entirely independent processes. Annotations should clarify the NOTCH-dependent mechanism where appropriate.
Neuromuscular Junction: The AGRN-dependent role at neuromuscular junctions is well-supported but substrate-specific (hao2025proteinofucosyltransferasesbiological pages 6-9). This should be annotated as a validated non-NOTCH function without overgeneralizing to broader neuronal signaling contexts.
Vascular Development: Evidence exists for roles in placental and uterine angiogenesis, but these are more specialized than the core NOTCH-dependent developmental functions (hao2025proteinofucosyltransferasesbiological pages 1-3).
Pyroptosis, Inflammatory Signaling, and Synaptic Remodeling: No evidence in the reviewed literature supports direct POFUT1 function in pyroptosis, canonical inflammatory signaling complexes, or synaptic remodeling beyond the AGRN-mediated neuromuscular junction effects (holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2, ajima2017pofut1pointmutationsthat pages 1-2).
Cytoplasmic, Nuclear, or Golgi Localization: These would represent incorrect annotations based on current evidence, which firmly places POFUT1 in the ER (holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2, ajima2017pofut1pointmutationsthat pages 1-2).
Direct Apoptosis Regulation: While POFUT1 loss can indirectly affect cell survival through NOTCH dysregulation, evidence does not support annotating direct pro- or anti-apoptotic molecular functions (hao2025proteinofucosyltransferasesbiological pages 21-22).
Cancer-Specific Functions as Core Biology: POFUT1's roles in tumor progression and immune evasion represent pathological context-specific functions that should not be treated as normal core biological processes (feng2024theglycogenealterations pages 1-2, li2024proteinofucosyltransferase1 pages 1-2, hao2025proteinofucosyltransferasesbiological pages 21-22). The PD-L1 stabilization function reported in hepatocellular carcinoma occurs independently of catalytic activity and may not generalize (li2024proteinofucosyltransferase1 pages 1-2).
Protein Processing Beyond Glycosylation: POFUT1 does not function as a protease or participate in proteolytic processing pathways. Its role is limited to O-fucosylation and the consequent effects on protein folding, stability, and trafficking (holdener2019proteinofucosylationstructure pages 1-3, takeuchi2017oglycosylationmodulatesthe pages 1-2).
Recent comprehensive reviews provide authoritative overviews of O-fucosylation biology:
Latest Reviews (2024-2025):
- Hao et al. (2025) "Protein O-Fucosyltransferases: Biological Functions and Molecular Mechanisms in Mammals" - Molecules 30(7):1470 (hao2025proteinofucosyltransferasesbiological pages 1-3, hao2025proteinofucosyltransferasesbiological pages 3-5, hao2025proteinofucosyltransferasesbiological pages 6-9)
- Hao et al. (2025) "FUT10 and FUT11 are protein O-fucosyltransferases that modify protein EMI domains" - Nature Chemical Biology 21:598-610 (hao2025proteinofucosyltransferasesbiological pages 1-3)
- Ameen & French (2025) "Genetic Diseases of Fucosylation: Insights from Model Organisms" - Genes 16(7):800 (hao2025proteinofucosyltransferasesbiological pages 1-3)
Recent Experimental Studies (2023-2024):
- Li et al. (2024) "Protein O-fucosyltransferase 1 promotes PD-L1 stability to drive immune evasion" - J Immunother Cancer 12:e008917 (li2024proteinofucosyltransferase1 pages 1-2)
- Feng et al. (2024) "The glycogene alterations and potential effects in esophageal squamous cell carcinoma" - Cell Mol Life Sci 81:481 (feng2024theglycogenealterations pages 1-2)
- Matsumoto et al. (2024) "Analysis of endogenous NOTCH1 from POFUT1 S162L patient fibroblasts" - bioRxiv (hao2025proteinofucosyltransferasesbiological pages 1-3)
Mechanistic and Structural Studies:
- Pandey et al. (2021) "Multifaceted regulation of Notch signaling by glycosylation" - Glycobiology (pandey2021multifacetedregulationof pages 1-3)
- Wang et al. (2022) "Significant Roles of Notch O-Glycosylation in Cancer" - Molecules 27(6):1783 (wang2022significantrolesof pages 1-3)
- Stanley & Tanwar (2022) "Regulation of myeloid and lymphoid cell development by O-glycans on Notch" - Front Mol Biosci 9:979724 (hao2025proteinofucosyltransferasesbiological pages 1-3)
- Takeuchi et al. (2017) "O-Glycosylation modulates the stability of epidermal growth factor-like repeats and thereby regulates Notch trafficking" - J Biol Chem 292(38):15964-15973 (takeuchi2017oglycosylationmodulatesthe pages 1-2)
Mouse Genetic Studies:
- Ajima et al. (2017) "Pofut1 point-mutations that disrupt O-fucosyltransferase activity destabilize the protein and abolish Notch1 signaling during mouse somitogenesis" - PLoS ONE 12(11):e0187248 (ajima2017pofut1pointmutationsthat pages 1-2)
- Vasudevan et al. (2015) "Peters Plus Syndrome Mutations Disrupt a Noncanonical ER Quality-Control Mechanism" - Current Biology 25(3):286-295 (vasudevan2015petersplussyndrome pages 1-3)
Foundational Reviews:
- Holdener & Haltiwanger (2019) "Protein O-fucosylation: structure and function" - Curr Opin Struct Biol 56:78-86 (holdener2019proteinofucosylationstructure pages 1-3)
- Schneider et al. (2017) "Biological functions of fucose in mammals" - Glycobiology 27(7):601-618 (schneider2017biologicalfunctionsof pages 1-2)
These references provide comprehensive coverage of POFUT1 molecular mechanisms, substrate specificity, biological functions, and disease relevance with priority given to recent authoritative sources published in 2023-2025.
References
(hao2025proteinofucosyltransferasesbiological pages 1-3): Huilin Hao, Benjamin M. Eberand, Mark Larance, and Robert S. Haltiwanger. Protein o-fucosyltransferases: biological functions and molecular mechanisms in mammals. Molecules, 30:1470, Mar 2025. URL: https://doi.org/10.3390/molecules30071470, doi:10.3390/molecules30071470. This article has 14 citations.
(holdener2019proteinofucosylationstructure pages 1-3): Bernadette C Holdener and Robert S Haltiwanger. Protein o-fucosylation: structure and function. Current opinion in structural biology, 56:78-86, Jun 2019. URL: https://doi.org/10.1016/j.sbi.2018.12.005, doi:10.1016/j.sbi.2018.12.005. This article has 175 citations and is from a peer-reviewed journal.
(schneider2017biologicalfunctionsof pages 1-2): Michael Schneider, Esam Al-Shareffi, and Robert S Haltiwanger. Biological functions of fucose in mammals. Glycobiology, 27 7:601-618, Jul 2017. URL: https://doi.org/10.1093/glycob/cwx034, doi:10.1093/glycob/cwx034. This article has 506 citations and is from a peer-reviewed journal.
(hao2025proteinofucosyltransferasesbiological pages 6-9): Huilin Hao, Benjamin M. Eberand, Mark Larance, and Robert S. Haltiwanger. Protein o-fucosyltransferases: biological functions and molecular mechanisms in mammals. Molecules, 30:1470, Mar 2025. URL: https://doi.org/10.3390/molecules30071470, doi:10.3390/molecules30071470. This article has 14 citations.
(wang2022significantrolesof pages 1-3): Weiwei Wang, Tetsuya Okajima, and Hideyuki Takeuchi. Significant roles of notch o-glycosylation in cancer. Molecules, 27:1783, Mar 2022. URL: https://doi.org/10.3390/molecules27061783, doi:10.3390/molecules27061783. This article has 23 citations.
(pandey2021multifacetedregulationof pages 1-3): Ashutosh Pandey, Nima Niknejad, and Hamed Jafar-Nejad. Multifaceted regulation of notch signaling by glycosylation. Glycobiology, May 2021. URL: https://doi.org/10.1093/glycob/cwaa049, doi:10.1093/glycob/cwaa049. This article has 81 citations and is from a peer-reviewed journal.
(ajima2017pofut1pointmutationsthat pages 1-2): Rieko Ajima, Emiko Suzuki, and Yumiko Saga. Pofut1 point-mutations that disrupt o-fucosyltransferase activity destabilize the protein and abolish notch1 signaling during mouse somitogenesis. PLoS ONE, 12:e0187248, Nov 2017. URL: https://doi.org/10.1371/journal.pone.0187248, doi:10.1371/journal.pone.0187248. This article has 23 citations and is from a peer-reviewed journal.
(hao2025proteinofucosyltransferasesbiological pages 21-22): Huilin Hao, Benjamin M. Eberand, Mark Larance, and Robert S. Haltiwanger. Protein o-fucosyltransferases: biological functions and molecular mechanisms in mammals. Molecules, 30:1470, Mar 2025. URL: https://doi.org/10.3390/molecules30071470, doi:10.3390/molecules30071470. This article has 14 citations.
(takeuchi2017oglycosylationmodulatesthe pages 1-2): Hideyuki Takeuchi, Hongjun Yu, Huilin Hao, Megumi Takeuchi, Atsuko Ito, Huilin Li, and Robert S. Haltiwanger. O-glycosylation modulates the stability of epidermal growth factor-like repeats and thereby regulates notch trafficking. Journal of Biological Chemistry, 292:15964-15973, Sep 2017. URL: https://doi.org/10.1074/jbc.m117.800102, doi:10.1074/jbc.m117.800102. This article has 148 citations and is from a domain leading peer-reviewed journal.
(vasudevan2015petersplussyndrome pages 1-3): Deepika Vasudevan, Hideyuki Takeuchi, Sumreet Singh Johar, Elaine Majerus, and Robert S. Haltiwanger. Peters plus syndrome mutations disrupt a noncanonical er quality-control mechanism. Current Biology, 25:286-295, Feb 2015. URL: https://doi.org/10.1016/j.cub.2014.11.049, doi:10.1016/j.cub.2014.11.049. This article has 104 citations and is from a highest quality peer-reviewed journal.
(feng2024theglycogenealterations pages 1-2): Xuefei Feng, Jinyan Chen, Jianhong Lian, Tianyue Dong, Yingzhen Gao, Xiaojuan Zhang, Yuanfang Zhai, Binbin Zou, Yanlin Guo, Enwei Xu, Yongping Cui, and Ling Zhang. The glycogene alterations and potential effects in esophageal squamous cell carcinoma. Cellular and Molecular Life Sciences: CMLS, Dec 2024. URL: https://doi.org/10.1007/s00018-024-05534-3, doi:10.1007/s00018-024-05534-3. This article has 6 citations.
(li2024proteinofucosyltransferase1 pages 1-2): Qianyu Li, Wenyun Guo, Yifei Qian, Songling Li, Linfeng Li, Zijun Zhu, Fan Wang, Yu Tong, Qiang Xia, and Yanfeng Liu. Protein o-fucosyltransferase 1 promotes pd-l1 stability to drive immune evasion and directs liver cancer to immunotherapy. Journal for Immunotherapy of Cancer, 12:e008917, Jun 2024. URL: https://doi.org/10.1136/jitc-2024-008917, doi:10.1136/jitc-2024-008917. This article has 11 citations and is from a domain leading peer-reviewed journal.
(hao2025proteinofucosyltransferasesbiological pages 3-5): Huilin Hao, Benjamin M. Eberand, Mark Larance, and Robert S. Haltiwanger. Protein o-fucosyltransferases: biological functions and molecular mechanisms in mammals. Molecules, 30:1470, Mar 2025. URL: https://doi.org/10.3390/molecules30071470, doi:10.3390/molecules30071470. This article has 14 citations.
(hao2025proteinofucosyltransferasesbiological pages 10-11): Huilin Hao, Benjamin M. Eberand, Mark Larance, and Robert S. Haltiwanger. Protein o-fucosyltransferases: biological functions and molecular mechanisms in mammals. Molecules, 30:1470, Mar 2025. URL: https://doi.org/10.3390/molecules30071470, doi:10.3390/molecules30071470. This article has 14 citations.
(hao2025proteinofucosyltransferasesbiological pages 19-21): Huilin Hao, Benjamin M. Eberand, Mark Larance, and Robert S. Haltiwanger. Protein o-fucosyltransferases: biological functions and molecular mechanisms in mammals. Molecules, 30:1470, Mar 2025. URL: https://doi.org/10.3390/molecules30071470, doi:10.3390/molecules30071470. This article has 14 citations.
GDP-fucose protein O-fucosyltransferase 1 (O-FucT-1; EC 2.4.1.221). HGNC:14988.
CAZy GT65. Chromosome 20. Glycobiology-project exemplar (Notch O-fucosylation axis).
POFUT1 transfers L-fucose from GDP-beta-L-fucose to the hydroxyl of a Ser/Thr in the
consensus C2-X(4,5)-S/T-C3 of EGF-like repeats, generating O-linked fucose. The enzyme
strictly requires a properly folded, disulfide-bonded EGF domain — it does not modify
linear peptides.
POFUT1 is a soluble ER-luminal enzyme retained by a C-terminal KDEL-like motif; it is
unique among fucosyltransferases in being ER-localized (FUT1-9 are Golgi type-II membrane
enzymes). O-fucosylation of Notch happens in the ER.
Implication for GOA review: ER annotations (IDA PMID:15653671; IBA; IEA; ISS) are correct
and the ER is CORE. The "membrane" (GO:0016020) annotations are problematic:
- HDA PMID:19946888 is an NK-cell membrane proteome MS catalog (1843 proteins; ~40% predicted membrane); POFUT1 is a soluble ER-luminal protein, so this is a fraction/contaminant-type assignment, uninformative.
- IDA PMID:11524432 and PMID:9023546 "membrane" annotations: both papers report the enzyme is largely soluble; PMID:9023546 recovered only 37% from membranes after Triton extraction of rat liver and attributes membrane association to a protease-susceptible stem. PMID:11524432 predicts a type-II TM anchor but Luo & Haltiwanger (PMID:15653671) later showed the active human/mammalian enzyme is soluble luminal. "membrane" is at best a trivial/uninformative location and is superseded by ER lumen. Mark as over-annotated rather than core.
O-fucose on Notch EGF repeats primes for Fringe (LFNG/MFNG/RFNG) GlcNAc elongation, which
modulates ligand (DLL1/DLL4, JAG1/JAG2) binding; POFUT1 is essential for Notch signal
transduction in mammals; loss traps Notch in the ER / blocks surface delivery and abolishes
signaling.
The "Notch signaling pathway" GO:0007219 (IEA from UniProt keyword / InterPro) — POFUT1 is
not a transducing core component of Notch; it post-translationally modifies the receptor in
the ER. "regulation of Notch signaling pathway" (GO:0008593) is the more accurate framing and
is independently supported by IMP. So GO:0007219 is best modified to GO:0008593 (or kept as
non-core); GO:0008593 IMP is the anchor.
Drosophila Ofut1 has an enzyme-independent chaperone activity required for Notch surface
expression; whether this extends to mammals is explicitly unresolved:
PMID:28334865, and mammalian data are context-dependent PMID:28334865. => Note the QC/folding-stabilization role (anchored to PMID:15653671 quality-control statement) but do NOT author a definitive mammalian "chaperone" molecular-function annotation. Capture as a suggested question/experiment.
Dowling-Degos disease 2 (DDD2, MIM 615327): autosomal dominant reticulate hyperpigmentation,
caused by haploinsufficiency (LoF) of POFUT1 (UniProt DISEASE; original Li et al. 2013
PMID:23684010, not cached). Structure paper tested the 4 DDD missense mutants: all except
M262T fail to rescue Notch1 signaling PMID:28334865. Disease is not used as a GO annotation here but informs the Notch-dependent mechanism.
MF peptide-O-fucosyltransferase activity GO:0046922:
- IDA PMID:11524432 -> ACCEPT (core; recombinant human enzyme characterization)
- IDA PMID:9023546 -> ACCEPT (core; original enzyme assay / acceptor specificity)
- IDA PMID:15653671 -> ACCEPT (core)
- TAS PMID:11698403 -> KEEP_AS_NON_CORE / caution: this is a Drosophila genome survey of fucosylated-glycan metabolism, not a human enzymatic characterization; TAS provenance is weak but the term is correct. Flag in reference_review (MISCITED risk — better human IDA refs exist).
- IBA GO_REF:0000033 -> ACCEPT (core; PAN-GO)
- IEA GO_REF:0000120 (EC 2.4.1.221 mapping) -> ACCEPT (core)
BP protein O-linked glycosylation via fucose GO:0036066:
- IDA PMID:11524432, PMID:9023546, PMID:15653671 -> ACCEPT (this is the process directly assayed)
- IBA, IEA(InterPro) -> ACCEPT
CC endoplasmic reticulum GO:0005783:
- IDA PMID:15653671 -> ACCEPT (core; the definitive ER-localization paper)
- IBA, IEA(GO_REF:0000044), ISS(GO_REF:0000024) -> ACCEPT (concordant)
BP regulation of Notch signaling pathway GO:0008593:
- IMP PMID:28334865 -> KEEP_AS_NON_CORE (well-supported downstream consequence; core function is ER catalysis)
- IBA GO_REF:0000033 -> KEEP_AS_NON_CORE
BP Notch signaling pathway GO:0007219:
- IEA GO_REF:0000002 (InterPro keyword) -> MODIFY to GO:0008593 (POFUT1 is a modifier of the receptor, not a transducing pathway component; the regulation term is more accurate and is the curated IMP framing)
CC membrane GO:0016020:
- HDA PMID:19946888 -> MARK_AS_OVER_ANNOTATED (NK membrane-proteome MS catalog; POFUT1 is soluble ER-luminal)
- IDA PMID:11524432 -> MARK_AS_OVER_ANNOTATED (trivial/uninformative; enzyme is largely soluble, superseded by ER lumen)
- IDA PMID:9023546 -> MARK_AS_OVER_ANNOTATED (same; only 37% membrane-associated via susceptible stem)
The Falcon deep-research report (POFUT1-deep-research-falcon.md) is broadly accurate and well
aligned with the primary literature. Findings I USED:
- ER-luminal soluble localization; ER quality-control of folded EGF repeats; avoid Golgi/cytosol/nucleus/plasma-membrane locations. (Concordant with PMID:15653671, PMID:28334865.)
- GO:0046922 / EC 2.4.1.221 as the defensible core MF; folded-EGF-repeat acceptor specificity. (Concordant with PMID:9023546, PMID:11524432.)
- Notch signaling as the central downstream role; somitogenesis/hematopoiesis are tissue-specific Notch-dependent manifestations (non-core); cancer roles are pathological/context-specific and should not drive normal-process GO annotation.
- Caution against annotating direct apoptosis, pyroptosis, inflammatory signaling, synaptic remodeling.
Findings I did NOT use / treated with caution (and why):
- Falcon's citation keys (e.g. hao2025..., holdener2019...) are review-derived and many were
NOT independently fetched/verified here; I anchored all YAML supporting_text to the six
cached primary PMIDs in GOA, not to Falcon's reference list.
- The "Ajima 2017 ... uterine/placental angiogenesis via uPA/RhoA" attribution in Falcon's BP
table looks like a citation-mismatch (Ajima 2017, PMID:28334865-adjacent PLoS ONE, is about
somitogenesis point-mutants, not angiogenesis). REJECTED as a basis for any annotation;
angiogenesis/uPA is not in GOA and not added.
- AGRN O-fucosylation / AChR clustering (from UniProt FUNCTION + Falcon): real and noted, but
there is NO GOA annotation for it and I could not fetch a primary human POFUT1-AGRN paper
from the cache, so I did not author a neuromuscular-junction core function; captured as a
suggested question instead.
- HCC PD-L1 stabilization "independent of catalytic activity" (li2024): interesting but a
single cancer-context, catalysis-independent claim; not fetched/verified, not annotated.
- Mammalian enzyme-independent chaperone activity: Falcon leans on it; primary source
(PMID:28334865) says this is explicitly unresolved in mammals -> kept as hypothesis only.
id: Q9H488
gene_symbol: POFUT1
product_type: PROTEIN
status: DRAFT
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
POFUT1 is a GDP-fucose protein O-fucosyltransferase 1 (O-FucT-1; EC 2.4.1.221),
the founding member of the CAZy GT65 family. It catalyzes transfer of L-fucose
from GDP-beta-L-fucose to the hydroxyl group of a serine or threonine within the
consensus C2-X(4,5)-S/T-C3 of epidermal growth factor (EGF)-like repeats,
forming an O-linked fucose. Catalysis is strictly dependent on a properly folded,
correctly disulfide-bonded EGF domain rather than on the linear sequence alone.
Unlike the Golgi type-II membrane fucosyltransferases (FUT1-9), POFUT1 is a
soluble enzyme of the endoplasmic reticulum lumen, retained there by a C-terminal
KDEL-like motif, so protein O-fucosylation occurs in the ER during biosynthesis
of EGF-repeat-containing secretory and cell-surface proteins. Because it modifies
only folded EGF domains, POFUT1 has been proposed to participate in a
non-canonical ER quality-control/folding-surveillance step for EGF-repeat
proteins. Its principal physiological substrates are the Notch receptors
(NOTCH1-4): O-fucose added by POFUT1 primes the EGF repeats for elongation by
Fringe beta-1,3-N-acetylglucosaminyltransferases, and the resulting O-glycans
modulate binding of Notch to its DLL and JAG ligands, making POFUT1 essential for
canonical Notch signal transduction in mammals. Loss of POFUT1 abolishes Notch
signaling and causes embryonic lethality in mice; in humans, heterozygous
loss-of-function (haploinsufficiency) causes the autosomal-dominant reticulate
pigmentation disorder Dowling-Degos disease 2.
alternative_products:
- name: '1'
id: Q9H488-1
- name: '2'
id: Q9H488-2
sequence_note: VSP_001809
existing_annotations:
- term:
id: GO:0005783
label: endoplasmic reticulum
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
Phylogenetic (PAN-GO) inference that POFUT1 is active in the endoplasmic
reticulum. This is the correct and core compartment: the active human/mammalian
enzyme is a soluble ER-luminal protein retained by a C-terminal KDEL-like motif,
and O-fucosylation of EGF-repeat substrates such as Notch occurs in the ER.
Concordant with the direct experimental IDA (PMID:15653671) and with the
deep-research synthesis favouring ER (not Golgi) as the active compartment.
Accept as core.
action: ACCEPT
supported_by:
- reference_id: PMID:15653671
supporting_text: O-FucT-1 is a soluble protein that localizes to the endoplasmic reticulum (ER)
- reference_id: file:human/POFUT1/POFUT1-deep-research-falcon.md
supporting_text: >-
POFUT1 is consistently described as an ER-localized, soluble luminal enzyme
- term:
id: GO:0008593
label: regulation of Notch signaling pathway
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetic inference that POFUT1 regulates Notch signaling. This is correct
and is the best-supported downstream biological role of POFUT1, independently
anchored by experimental IMP (PMID:28334865). However it is a consequence of
the core ER catalytic function (O-fucosylation of Notch EGF repeats) rather
than the core function itself, so keep as a valid non-core process annotation.
action: KEEP_AS_NON_CORE
- term:
id: GO:0036066
label: protein O-linked glycosylation via fucose
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetic inference for the O-fucosylation process. This is the exact
biological process POFUT1 carries out and is directly supported by multiple
experimental IDA annotations (PMID:11524432, PMID:9023546, PMID:15653671).
Core. Accept.
action: ACCEPT
- term:
id: GO:0046922
label: peptide-O-fucosyltransferase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetic inference of the catalytic activity. GO:0046922 (transfer of
alpha-L-fucosyl from GDP-beta-L-fucose to a protein Ser/Thr hydroxyl) is the
most specific GO molecular-function term for the EC 2.4.1.221 reaction and is
the core activity of POFUT1, directly supported by experimental IDA. Accept.
action: ACCEPT
- term:
id: GO:0005783
label: endoplasmic reticulum
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: >-
Electronic mapping from the UniProt Subcellular Location (Endoplasmic
reticulum). Concordant with the experimental IDA (PMID:15653671) and the
KDEL-like ER-retention motif. Correct core location. Accept.
action: ACCEPT
- term:
id: GO:0007219
label: Notch signaling pathway
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
InterPro-keyword electronic annotation to the Notch signaling pathway itself.
POFUT1 is not a transducing/core component of the Notch pathway; it is an ER
enzyme that post-translationally O-fucosylates Notch EGF repeats, thereby
regulating the pathway. The more accurate and curator-supported framing is
"regulation of Notch signaling pathway" (GO:0008593), which is also the term
used for the experimental IMP (PMID:28334865). Modify to the regulation term.
action: MODIFY
proposed_replacement_terms:
- id: GO:0008593
label: regulation of Notch signaling pathway
- term:
id: GO:0036066
label: protein O-linked glycosylation via fucose
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
InterPro-based electronic annotation to the O-fucosylation process; identical
in content to the experimentally supported IDA annotations. Correct core
process. Accept.
action: ACCEPT
- term:
id: GO:0046922
label: peptide-O-fucosyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic annotation derived from the EC 2.4.1.221 / InterPro mapping. This
is the correct, specific core molecular function and matches the experimental
IDA. Accept.
action: ACCEPT
- term:
id: GO:0036066
label: protein O-linked glycosylation via fucose
evidence_type: IDA
original_reference_id: PMID:11524432
qualifier: involved_in
review:
summary: >-
Direct experimental evidence: cloning and expression of recombinant human
O-FucT-1 reproduced the O-fucosyltransferase enzymatic and kinetic properties
of the enzyme purified from CHO cells, establishing that POFUT1 carries out
O-linked fucosylation of EGF domains. Core process. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:11524432
supporting_text: >-
Expression of a soluble form of human O-FucT-1 in insect cells yielded a
protein of the predicted molecular weight with O-FucT-1 kinetic and
enzymatic properties similar to those of O-FucT-1 purified from CHO cells
- term:
id: GO:0036066
label: protein O-linked glycosylation via fucose
evidence_type: IDA
original_reference_id: PMID:9023546
qualifier: involved_in
review:
summary: >-
Direct experimental evidence: the original GDP-fucose:polypeptide
fucosyltransferase assay demonstrated O-glycosidic attachment of fucose to a
Ser/Thr in EGF domains, with a requirement for a properly folded
(disulfide-bonded) EGF domain. Core process. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:9023546
supporting_text: >-
The enzyme catalyzes the reaction that attaches fucose through an
O-glycosidic linkage to a conserved serine or threonine residue in EGF
domains
- term:
id: GO:0046922
label: peptide-O-fucosyltransferase activity
evidence_type: IDA
original_reference_id: PMID:11524432
qualifier: enables
review:
summary: >-
Direct experimental demonstration of peptide-O-fucosyltransferase activity by
recombinant human POFUT1 (the paper to which UniProt assigns EC 2.4.1.221).
This is the core, defining molecular function of the gene. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:11524432
supporting_text: >-
Expression of a soluble form of human O-FucT-1 in insect cells yielded a
protein of the predicted molecular weight with O-FucT-1 kinetic and
enzymatic properties similar to those of O-FucT-1 purified from CHO cells
- term:
id: GO:0046922
label: peptide-O-fucosyltransferase activity
evidence_type: IDA
original_reference_id: PMID:9023546
qualifier: enables
review:
summary: >-
Direct experimental demonstration: the GDP-fucose:polypeptide
fucosyltransferase activity was assayed using recombinant factor VII EGF-1 as
acceptor and GDP-fucose as donor, with the diagnostic requirement for a
correctly folded/disulfide-bonded EGF domain. This is the core molecular
function. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:9023546
supporting_text: >-
the enzyme appears to require more than just a consensus primary sequence
and likely requires that the EGF domain disulfide bonds be properly formed
- term:
id: GO:0005783
label: endoplasmic reticulum
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: located_in
review:
summary: >-
Sequence-similarity transfer of ER localization (from UniProtKB:Q6EV70). Fully
concordant with the direct experimental ER localization in human cells
(PMID:15653671) and the family expectation. Correct core location. Accept.
action: ACCEPT
- term:
id: GO:0008593
label: regulation of Notch signaling pathway
evidence_type: IMP
original_reference_id: PMID:28334865
qualifier: involved_in
review:
summary: >-
Strong experimental (mutant-phenotype) evidence: CRISPR knockout of POFUT1 in
U2OS cells suppresses both normal ligand-dependent Notch1 signaling and the
ligand-independent signaling of leukemogenic Notch1 mutants, and blocks
delivery of Notch1 to the cell surface; signaling is rescued by wild-type
POFUT1 but not efficiently by the active-site R240A variant. POFUT1 thus
regulates Notch signaling. This is the best-supported downstream role but is a
consequence of the ER catalytic function; keep as a valid non-core process.
action: KEEP_AS_NON_CORE
supported_by:
- reference_id: PMID:28334865
supporting_text: >-
Normal and oncogenic signaling are rescued by wild-type POFUT1 but rescue is
impaired by an active-site R240A mutation
- term:
id: GO:0016020
label: membrane
evidence_type: HDA
original_reference_id: PMID:19946888
qualifier: located_in
review:
summary: >-
High-throughput mass-spectrometry catalog of the NK-like (YTS) cell membrane
proteome (1843 proteins), in which POFUT1 was detected. POFUT1 is a soluble
ER-luminal enzyme; detection in a crude membrane preparation is not
informative of its true localization and conflicts with the experimentally
established soluble ER-luminal localization (PMID:15653671). Generic, trivial
"membrane" location; over-annotation.
action: MARK_AS_OVER_ANNOTATED
- term:
id: GO:0005783
label: endoplasmic reticulum
evidence_type: IDA
original_reference_id: PMID:15653671
qualifier: located_in
review:
summary: >-
Definitive direct experimental localization: human O-FucT-1 is a soluble
protein localizing to the ER and retained there by a C-terminal KDEL-like
sequence, and O-fucosylation of proteins occurs in the ER. This establishes
the ER as the core compartment of POFUT1 and is the key reference
distinguishing it from the Golgi FUT family. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:15653671
supporting_text: O-FucT-1 is retained in the ER by a KDEL-like sequence at its C terminus
- term:
id: GO:0036066
label: protein O-linked glycosylation via fucose
evidence_type: IDA
original_reference_id: PMID:15653671
qualifier: involved_in
review:
summary: >-
Direct experimental evidence that enzymatic addition of O-fucose to proteins
(Notch) occurs in the ER, catalyzed by O-FucT-1. Supports the core
O-fucosylation process annotation and locates it to the ER. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:15653671
supporting_text: enzymatic addition of O-fucose to proteins occurs in the ER
- term:
id: GO:0046922
label: peptide-O-fucosyltransferase activity
evidence_type: IDA
original_reference_id: PMID:15653671
qualifier: enables
review:
summary: >-
Direct experimental study of the localization and substrate behavior of
protein O-fucosyltransferase 1 (O-FucT-1), which adds O-fucose to EGF-like
repeats. Supports the core peptide-O-fucosyltransferase activity. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:15653671
supporting_text: >-
protein O-fucosyltransferase 1 (O-FucT-1), which is responsible for adding
O-fucose to epidermal growth factor-like repeats
- term:
id: GO:0016020
label: membrane
evidence_type: IDA
original_reference_id: PMID:11524432
qualifier: located_in
review:
summary: >-
"Membrane" location inferred from a predicted N-terminal type-II transmembrane
sequence in the cloned cDNA. However the same and subsequent work show the
active enzyme is largely soluble, and PMID:15653671 demonstrated that the
mammalian enzyme is a soluble ER-luminal protein. "membrane" (GO:0016020) is a
trivial, uninformative term here and is superseded by the ER (lumen)
localization. Over-annotation.
action: MARK_AS_OVER_ANNOTATED
- term:
id: GO:0016020
label: membrane
evidence_type: IDA
original_reference_id: PMID:9023546
qualifier: located_in
review:
summary: >-
"Membrane" location from the original enzyme purification: most activity was
soluble, and only ~37% could be recovered from rat-liver membranes by Triton
extraction, attributed to a protease-susceptible stem rather than a stable
integral-membrane location. Combined with the later demonstration of soluble
ER-luminal localization (PMID:15653671), the generic "membrane" term is
uninformative and over-annotated.
action: MARK_AS_OVER_ANNOTATED
- term:
id: GO:0046922
label: peptide-O-fucosyltransferase activity
evidence_type: TAS
original_reference_id: PMID:11698403
qualifier: enables
review:
summary: >-
TAS annotation of the catalytic activity. The cited paper is a Drosophila
melanogaster genome-wide survey of enzymes in fucosylated-glycan metabolism
(which identified fly O-fucosyltransferase genes), not a characterization of
human POFUT1 activity. The molecular-function term itself is correct and core,
but the supporting reference is a weak choice for the human gene; far stronger
human IDA evidence (PMID:11524432, PMID:9023546, PMID:15653671) supports the
same term. Accept the (correct, core) term but flag the weak/miscited
provenance in reference_review; the human IDA annotations are the real support.
action: ACCEPT
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:11524432
title: Modification of epidermal growth factor-like repeats with O-fucose. Molecular
cloning and expression of a novel GDP-fucose protein O-fucosyltransferase.
findings:
- statement: >-
Molecular cloning of human POFUT1 (O-FucT-1) cDNA; recombinant soluble enzyme
reproduces the O-fucosyltransferase activity and kinetics of the natively
purified enzyme. This is the reference to which UniProt assigns EC 2.4.1.221.
supporting_text: >-
Expression of a soluble form of human O-FucT-1 in insect cells yielded a
protein of the predicted molecular weight with O-FucT-1 kinetic and enzymatic
properties similar to those of O-FucT-1 purified from CHO cells.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed/UniProt-verified primary cloning and enzymatic characterization of human
POFUT1 (Wang et al. 2001, JBC). Abstract-only in cache; supporting_text is a
verbatim quote from the abstract. Anchors the core MF and O-fucosylation
process annotations. Note the abstract predicts a type-II TM anchor, but the
active enzyme is later shown to be soluble ER-luminal (PMID:15653671).
- id: PMID:11698403
title: Composition of Drosophila melanogaster proteome involved in fucosylated glycan
metabolism.
findings:
- statement: >-
Genome-wide survey of Drosophila enzymes in fucosylated-glycan metabolism that
identified fly O-fucosyltransferase genes; not a characterization of human
POFUT1.
supporting_text: >-
We also identified two novel genes coding for O-fucosyltransferases and a gene
responsible for a fucosidase enzyme in the Drosophila genome.
reference_review:
relevance: LOW
correctness: MISCITED
review_notes: >-
PubMed-verified, but this is a Drosophila genome bioinformatics survey, not a
study of human POFUT1 enzymatic activity. It is a weak/inappropriate basis for
a TAS human peptide-O-fucosyltransferase-activity annotation; the same MF term
is far better supported by human IDA (PMID:11524432, PMID:9023546,
PMID:15653671).
- id: PMID:15653671
title: O-fucosylation of notch occurs in the endoplasmic reticulum.
findings:
- statement: >-
Human O-FucT-1 (POFUT1) is a soluble protein that localizes to the ER, retained
by a C-terminal KDEL-like motif; O-fucosylation of proteins (Notch) occurs in
the ER, distinguishing POFUT1 from the Golgi FUT family.
supporting_text: >-
O-FucT-1 is a soluble protein that localizes to the endoplasmic reticulum (ER).
- statement: >-
Because O-FucT-1 recognizes only properly folded EGF-like repeats, and given
its unique ER localization, it may function in a quality-control step.
supporting_text: >-
The fact that O-FucT-1 recognizes properly folded epidermal growth factor-like
repeats, together with this unique localization, suggests that it may play a
role in quality control.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified primary localization study (Luo & Haltiwanger 2005, JBC).
Abstract-only in cache; supporting_text quotes are verbatim from the abstract.
Definitive evidence for soluble ER-luminal localization and KDEL-like retention;
basis for treating ER as core and Golgi/membrane as incorrect/uninformative.
- id: PMID:19946888
title: Defining the membrane proteome of NK cells.
findings:
- statement: >-
Large-scale MS catalog of the NK-like (YTS) cell membrane proteome (1843
proteins) in which POFUT1 was detected in a crude membrane fraction.
supporting_text: >-
Mass spectrometric analysis identified 1843 proteins with high confidence scores.
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
PubMed-verified high-throughput membrane-proteome MS study. POFUT1's presence in
a crude membrane fraction is the basis of the HDA "membrane" annotation but is
not informative of its true soluble ER-luminal localization; contributes only a
generic, over-annotated location.
- id: PMID:28334865
title: Structure of human POFUT1, its requirement in ligand-independent oncogenic
Notch signaling, and functional effects of Dowling-Degos mutations.
findings:
- statement: >-
POFUT1 is an ER-resident enzyme that O-fucosylates EGF-like repeats using
GDP-fucose and is essential for Notch signal transduction in mammals.
supporting_text: >-
POFUT1 is an ER-resident protein that catalyzes O-linked fucosylation of an
acceptor site on an EGF-like repeat of a recipient protein, using GDP-fucose as
the donor substrate.
- statement: >-
CRISPR knockout of POFUT1 suppresses normal and oncogenic ligand-independent
Notch1 signaling and blocks Notch1 surface delivery; rescue requires catalytic
activity (impaired by active-site R240A). Supports the IMP regulation-of-Notch
annotation.
supporting_text: >-
Normal and oncogenic signaling are rescued by wild-type POFUT1 but rescue is
impaired by an active-site R240A mutation.
- statement: >-
Reported Dowling-Degos missense mutations (except M262T) fail to rescue Notch1
signaling, consistent with loss of function underlying the disease.
supporting_text: >-
The reported Dowling-Degos mutations of POFUT1, except for M262T, fail to rescue
Notch1 signaling efficiently in the CRISPR-engineered POFUT1-/- background.
- statement: >-
Whether the enzyme-independent chaperone activity described for Drosophila Ofut1
extends to mammalian POFUT1 is explicitly unresolved.
supporting_text: >-
Whether the enzyme-independent chaperone activity of Pofut1 extends to mammals is
not clear.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified; full text available in cache. Provides the human POFUT1 crystal
structures (GDP-fucose complex), the IMP evidence for regulation of Notch
signaling, and functional analysis of Dowling-Degos mutations. Anchors the
Notch-regulation annotation and the cautious (non-core) treatment of a mammalian
chaperone role.
- id: PMID:9023546
title: Identification of a GDP-L-fucose:polypeptide fucosyltransferase and enzymatic
addition of O-linked fucose to EGF domains.
findings:
- statement: >-
Original biochemical identification of the GDP-fucose:polypeptide
fucosyltransferase: it attaches fucose by an O-glycosidic linkage to a Ser/Thr
in EGF domains.
supporting_text: >-
The enzyme catalyzes the reaction that attaches fucose through an O-glycosidic
linkage to a conserved serine or threonine residue in EGF domains.
- statement: >-
The enzyme requires a properly folded, disulfide-bonded EGF domain rather than a
linear consensus peptide, establishing folding-dependent acceptor recognition.
supporting_text: >-
the enzyme appears to require more than just a consensus primary sequence and
likely requires that the EGF domain disulfide bonds be properly formed
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified original enzyme-activity characterization (Wang et al. 1996,
Glycobiology). Abstract-only in cache; supporting_text quotes are verbatim.
Establishes the core peptide-O-fucosyltransferase activity and the
folded-EGF-domain acceptor requirement.
- id: file:human/POFUT1/POFUT1-deep-research-falcon.md
title: FutureHouse Falcon deep-research report for POFUT1
findings:
- statement: >-
Deep-research synthesis: POFUT1 is best supported as a soluble ER-luminal
protein O-fucosyltransferase acting on folded EGF repeats, with Notch O-fucosylation
as the central downstream axis; Golgi/cytosol/nucleus/plasma-membrane localizations
and direct apoptosis/pyroptosis roles are over-extensions to avoid.
supporting_text: >-
POFUT1 is consistently described as an ER-localized, soluble luminal enzyme
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
FutureHouse Falcon deep-research report. Conclusions are concordant with the
curated review and with the primary literature. Used only to anchor the
ER-localization synthesis; all substantive annotations are cited to the cached
primary PMIDs rather than to Falcon's (largely review-derived, unverified)
citation list. One Falcon claim (Ajima 2017 attributed to uterine/placental
angiogenesis via uPA/RhoA) appears to be a citation mismatch and was rejected.
core_functions:
- description: >-
POFUT1 catalyzes transfer of L-fucose from GDP-beta-L-fucose to the hydroxyl of a
Ser/Thr residue in the consensus C2-X(4,5)-S/T-C3 of a properly folded,
disulfide-bonded EGF-like repeat, producing O-linked fucose (EC 2.4.1.221). This
is the defining catalytic activity of the gene.
molecular_function:
id: GO:0046922
label: peptide-O-fucosyltransferase activity
directly_involved_in:
- id: GO:0036066
label: protein O-linked glycosylation via fucose
locations:
- id: GO:0005783
label: endoplasmic reticulum
supported_by:
- reference_id: PMID:9023546
supporting_text: >-
The enzyme catalyzes the reaction that attaches fucose through an O-glycosidic
linkage to a conserved serine or threonine residue in EGF domains
- reference_id: PMID:11524432
supporting_text: >-
Expression of a soluble form of human O-FucT-1 in insect cells yielded a
protein of the predicted molecular weight with O-FucT-1 kinetic and enzymatic
properties similar to those of O-FucT-1 purified from CHO cells
- reference_id: PMID:15653671
supporting_text: O-FucT-1 is a soluble protein that localizes to the endoplasmic reticulum (ER)
proposed_new_terms:
- proposed_name: protein O-fucosylation-dependent endoplasmic reticulum quality control
proposed_definition: >-
A protein folding-coupled process in which an endoplasmic-reticulum-localized
protein O-fucosyltransferase selectively modifies properly folded, correctly
disulfide-bonded EGF-like repeats with O-linked fucose, stabilizing the folded
domain and promoting forward trafficking of the substrate protein out of the ER.
justification: >-
POFUT1 modifies only folded EGF repeats (PMID:9023546) and is uniquely localized
to the ER lumen (PMID:15653671), which led the authors to propose a non-canonical
ER quality-control / folding-surveillance role distinct from the calnexin/calreticulin
N-glycan pathway. There is no GO term capturing O-fucosylation-coupled ER folding
surveillance of EGF-repeat proteins; existing terms cover either generic O-fucosylation
(GO:0036066) or generic ER quality control. A specific term would let POFUT1 (and POFUT2)
be annotated to this folding-coupled QC function. Proposed as a child of protein folding
/ ER protein-containing complex quality control; this is a hypothesis flagged for expert
review rather than a settled activity.
suggested_questions:
- question: >-
Does human POFUT1 retain the enzyme-independent chaperone activity described for
Drosophila Ofut1 (required for Notch surface expression), or is the mammalian
requirement for Notch trafficking entirely catalysis-dependent? PMID:28334865 shows
the active-site R240A mutant only partially rescues, and states the mammalian
chaperone question is unresolved.
- question: >-
Beyond Notch receptors, which physiological human substrates (e.g. AGRN/agrin and
its role in acetylcholine-receptor clustering, Notch ligands DLL1/DLL4/JAG1/JAG2,
other EGF-repeat ECM/cell-surface proteins) are O-fucosylated by POFUT1 in vivo, and
is any of these functionally significant independent of Notch?
- question: >-
What is the mechanistic basis by which heterozygous POFUT1 loss-of-function
(haploinsufficiency) produces the skin-restricted Dowling-Degos disease 2 phenotype
while complete loss is embryonic-lethal via global Notch failure?
suggested_experiments:
- description: >-
Separation-of-function rescue in POFUT1-null cells comparing wild-type enzyme,
catalytically dead active-site mutants (e.g. R240A/S356F), and ER-retention-motif
deletions, scoring Notch1 surface delivery, EGF-repeat O-fucosylation by mass
spectrometry, and Notch reporter signaling, to dissect catalytic versus
chaperone/QC contributions in mammalian cells.
- description: >-
Site-resolved glycoproteomic mapping of O-fucose (and Fringe-extended) glycans on
endogenous NOTCH1-4 and candidate non-Notch EGF-repeat substrates in
POFUT1-knockout versus wild-type cells, to define the in vivo substrate repertoire
and the stoichiometry/site occupancy of POFUT1-dependent modification.
- description: >-
In vitro folding/stability assays (thermal/chemical unfolding, limited proteolysis)
on individual EGF repeats with and without O-fucose to test the proposed
folding-stabilization/quality-control function, ideally combined with kinetic
measurement of POFUT1 acceptor preference for folded versus reduced/unfolded EGF domains.